These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20665)

  • 1. Biogenic amine synthesis defect in dihydropteridine reductase deficiency.
    Koslow SH; Butler IJ
    Science; 1977 Nov; 198(4316):522-3. PubMed ID: 20665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disorder of biogenic amines in dihydropteridine reductase deficiency.
    Butler IJ; Koslow SH; Krumholz A; Holtzman NA; Kaufman S
    Ann Neurol; 1978 Mar; 3(3):224-30. PubMed ID: 27135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropteridine reductase deficiency associated with severe neurologic disease and mild hyperphenylalaninemia.
    Brewster TG; Moskowitz MA; Kaufman S; Breslow JL; Milstien S; Abroms IF
    Pediatrics; 1979 Jan; 63(1):94-9. PubMed ID: 312482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folinic acid therapy in treatment of dihydropteridine reductase deficiency.
    Irons M; Levy HL; O'Flynn ME; Stack CV; Langlais PJ; Butler IJ; Milstien S; Kaufman S
    J Pediatr; 1987 Jan; 110(1):61-7. PubMed ID: 2878984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia.
    Butler IJ; O'Flynn ME; Seifert WE; Howell RR
    J Pediatr; 1981 May; 98(5):729-33. PubMed ID: 6112253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.
    Castells S; Chakrabarti C; Winsberg BG; Hurwic M; Perel JM; Nyhan WL
    J Autism Dev Disord; 1979 Mar; 9(1):95-103. PubMed ID: 312282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant phenylketonuria caused by biopterin synthetase deficiency. Study of neuromediator catabolites in the cerebrospinal fluid during treatment].
    Malpuech G; Guyon A; Demeocq F; Piton A; Boespflug O; Vanlieferinghen P
    Arch Fr Pediatr; 1984 Jan; 41(1):5-8. PubMed ID: 6202269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of cerebral biogenic amine synthesis in a patient receiving high-dose methotrexate.
    Millot F; Dhondt JL; Hayte JM; Bauters F
    Am J Pediatr Hematol Oncol; 1992 Aug; 14(3):276-8. PubMed ID: 1380777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphenylalaninemia due to dihydropteridine reductase deficiency. Assay of the enzyme in fibroblasts from affected infants, heterozygotes, and in normal amniotic fluid cells.
    Milstien S; Holtzman NA; O'Flynn ME; Thomas GH; Butler IJ; Kaufman S
    J Pediatr; 1976 Nov; 89(5):763-6. PubMed ID: 978323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two mutations of dihydropteridine reductase deficiency.
    Ponzone A; Guardamagna O; Ferraris S; Bracco G; Niederwieser A; Cotton RG
    Arch Dis Child; 1988 Feb; 63(2):154-7. PubMed ID: 2894818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Concentrations of Neurotransmitters in a Greek Pediatric Reference Population.
    Vilanakis E; Papakonstantinou E; Paramera E; Argyri I; Drakou E; Kokkinou E; Zouvelou V; Outsika C; Pons R
    Neuropediatrics; 2023 Apr; 54(2):126-133. PubMed ID: 36442788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperphenylalaninaemia due to dihydropteridine reductase deficiency.
    Gröbe H; Bartholome K; Milstien S; Kaufman S
    Eur J Pediatr; 1978 Sep; 129(2):93-8. PubMed ID: 28230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in tetrahydrobiopterin content and neurotransmitter amine biosynthesis in rat brain by an inhibitor of guanosine triphosphate cyclohydrolase.
    Suzuki S; Watanabe Y; Tsubokura S; Kagamiyama H; Hayaishi O
    Brain Res; 1988 Apr; 446(1):1-10. PubMed ID: 2453255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoaminergic effects of folinic acid, L-DOPA, and 5-hydroxytryptophan in dihydropteridine reductase deficiency.
    Goldstein DS; Hahn SH; Holmes C; Tifft C; Harvey-White J; Milstien S; Kaufman S
    J Neurochem; 1995 Jun; 64(6):2810-3. PubMed ID: 7760062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
    Ramaekers VT; Senderek J; Häusler M; Häring M; Abeling N; Zerres K; Bergmann C; Heimann G; Blau N
    Mol Genet Metab; 2001 Jun; 73(2):179-87. PubMed ID: 11386854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropteridine reductase deficiency: non-response to oral tetrahydrobiopterin load test.
    Lipson A; Yu J; O'Halloran M; Potter M; Wilken B
    J Inherit Metab Dis; 1984; 7(2):69-71. PubMed ID: 6434829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro.
    Bartholomé K; Byrd DJ; Kaufman S; Milstien S
    Pediatrics; 1977 May; 59(5):757-61. PubMed ID: 300866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter therapy and diet in malignant phenylketonuria.
    Ponzone A; Guardamagna O; Ferraris S; Biasetti S; Bracco G; Niederwieser A
    Eur J Pediatr; 1987 Jan; 146(1):93-4. PubMed ID: 2438135
    [No Abstract]   [Full Text] [Related]  

  • 20. Central serotonin deficiency--a factor which increases depression vulnerability?
    van Praag HM; de Haan S
    Acta Psychiatr Scand Suppl; 1980; 280():89-96. PubMed ID: 6157306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.